Advertisement
Screener

SOLVENTUM CORPORATION (SOLV) Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent

2.8 / 5 stars · 68/120 Roast Me

SOLVENTUM CORPORATION Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent

SOLVENTUM CORPORATION (SOLV) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 · last filed 2026-08-05

  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2026-06-30 was $2.00M.
  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2026-03-31 was $15.00M.
  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2025-12-31 was -$10.00M, a 300.00% decline year-over-year.
  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for the quarter ending 2025-09-30 was $20.00M.
  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for fiscal 2025 was -$12.00M, a 250.00% decline from fiscal 2024.
  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for fiscal 2024 was $8.00M.
  • SOLVENTUM CORPORATION other comprehensive income (loss), tax, portion attributable to parent for fiscal 2023 was -$17.00M.
Period endOther Comprehensive Income (Loss), Tax, Portion Attributable to Parent 3 monthOther Comprehensive Income (Loss), Tax, Portion Attributable to Parent 6 monthOther Comprehensive Income (Loss), Tax, Portion Attributable to Parent 9 monthOther Comprehensive Income (Loss), Tax, Portion Attributable to Parent 12 month
2026-06-30$2.00M
10-Q · filed 2026-08-05
$17.00M
10-Q · filed 2026-08-05
$7.00M
derived: sum of 3 quarters · filed 2026-08-05
$27.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$15.00M
10-Q · filed 2026-05-05
$5.00M
derived: sum of 2 quarters · filed 2026-05-05
$25.00M
derived: sum of 3 quarters · filed 2026-05-05
$4.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$10.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$10.00M
derived: sum of 2 quarters · filed 2026-02-27
-$11.00M
derived: sum of 3 quarters · filed 2026-08-05
-$12.00M
10-K · filed 2026-02-27
2025-09-30$20.00M
10-Q · filed 2025-11-06
-$1.00M
derived: sum of 2 quarters · filed 2026-08-05
-$2.00M
10-Q · filed 2025-11-06
$3.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$21.00M
10-Q · filed 2026-08-05
-$22.00M
10-Q · filed 2026-08-05
-$17.00M
derived: sum of 3 quarters · filed 2026-08-05
-$18.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$1.00M
10-Q · filed 2026-05-05
$4.00M
derived: sum of 2 quarters · filed 2026-05-05
$3.00M
derived: sum of 3 quarters · filed 2026-05-05
$7.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$5.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$4.00M
derived: sum of 2 quarters · filed 2026-02-27
$8.00M
derived: sum of 3 quarters · filed 2026-02-27
$8.00M
10-K · filed 2026-02-27
2024-09-30-$1.00M
10-Q · filed 2025-11-06
$3.00M
derived: sum of 2 quarters · filed 2025-11-06
$3.00M
10-Q · filed 2025-11-06
2024-06-30$4.00M
10-Q · filed 2025-08-08
$4.00M
derived: sum of 2 quarters · filed 2025-08-08
2024-03-31$0.00
10-Q · filed 2024-05-10
2023-12-31-$17.00M
10-K · filed 2026-02-27
2023-03-31$0.00
10-Q · filed 2024-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B